Liao, H.X. et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J. Virol. Methods 158, 171-179

Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, United States.
Journal of virological methods (Impact Factor: 1.88). 07/2009; 158(1-2):171-9. DOI: 10.1016/j.jviromet.2009.02.014
Source: PubMed

ABSTRACT Defining human B cell repertoires to viral pathogens is critical for design of vaccines that induce broadly protective antibodies to infections such as HIV-1 and influenza. Single B cell sorting and cloning of immunoglobulin (Ig) heavy- and light-chain variable regions (V(H) and V(L)) is a powerful technology for defining anti-viral B cell repertoires. However, the Ig-cloning step is time-consuming and prevents high-throughput analysis of the B cell repertoire. Novel linear Ig heavy- and light-chain gene expression cassettes were designed to express Ig V(H) and V(L) genes isolated from sorted single B cells as IgG1 antibody without a cloning step. The cassettes contain all essential elements for transcriptional and translational regulation, including CMV promoter, Ig leader sequences, constant region of IgG1 heavy- or Ig light-chain, poly(A) tail and substitutable V(H) or V(L) genes. The utility of these Ig gene expression cassettes was established using synthetic V(H) or V(L) genes from an anti-HIV-1 gp41 mAb 2F5 as a model system, and validated further using V(H) and V(L) genes isolated from cloned EBV-transformed antibody-producing cell lines. Finally, this strategy was successfully used for rapid production of recombinant influenza mAbs from sorted single human plasmablasts after influenza vaccination. These Ig gene expression cassettes constitute a highly efficient strategy for rapid expression of Ig genes for high-throughput screening and analysis without cloning.

Download full-text


Available from: Ruijun Zhang, Oct 31, 2014
1 Follower
  • Source
    • "Transient and recombinant antibody expressions were performed as previously described (Liao et al., 2009, 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In HIV-1, the ability to mount antibody responses to conserved, neutralizing epitopes is critical for protection. Here we have studied the light chain usage of human and rhesus macaque antibodies targeted to a dominant region of the HIV-1 envelope second variable (V2) region involving lysine (K) 169, the site of immune pressure in the RV144 vaccine efficacy trial. We found that humans and rhesus macaques used orthologous lambda variable gene segments encoding a glutamic acid-aspartic acid (ED) motif for K169 recognition. Structure determination of an unmutated ancestor antibody demonstrated that the V2 binding site was preconfigured for ED motif-mediated recognition prior to maturation. Thus, light chain usage for recognition of the site of immune pressure in the RV144 trial is highly conserved across species. These data indicate that the HIV-1 K169-recognizing ED motif has persisted over the diversification between rhesus macaques and humans, suggesting an evolutionary advantage of this antibody recognition mode. Copyright © 2014 Elsevier Inc. All rights reserved.
    Immunity 12/2014; 41(6):909-918. DOI:10.1016/j.immuni.2014.11.014 · 19.75 Impact Factor
  • Source
    • "On the other hand, the single B cell-based human monoclonal antibody (MoAb) gene PCR cloning method has been developed as a rapid and simple technology without undesirable selection or bias in recent years. Using this technology, several researchers have demonstrated that human immunodeficiency virus (HIV)-infected subjects possessed neutralizing serum antibodies that neutralized the majority of viruses with diverse genetic subtypes, and successfully identified and synthesized a human monoclonal antibody from a single memory-B cell that neutralized over 90% of HIV-1 isolates [18] [19]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Antibody direct cloning from single B cells is simple and efficient and has been successful in antibody identification of infectious diseases. However, although a recent whole-exome sequencing revealed abundant heterogeneic mutation accumulation in cancers, identification and synthesis of autoantibodies against specific cancer-associated antigens is still difficult in cancer patients owing to the very small number of B cells producing autoantibodies. In the present study, to identify autoantibodies targeting tumor antigens, we measured the titer of autoantibodies in high-grade glioma patients’ plasma and identified two patients with elevated autoantibodies to a few transmembrane proteins. Specific B cells producing autoantibody against vascular endothelial growth factor receptor (VEGFR) 2 were immunostained with labeled protein and anti-human IgG antibody, and then collected by a single cell sorter. Finally, 22 antibody genes were successfully identified using direct IgG cloning from single B cell mRNA, and two antibody clones were found to have significant VEGFR2-specific binding affinity. The current direct human IgG gene cloning technique for identifying human antibodies derived from IgG-memory B cells avoids time-consuming procedures such as phage display-based antibody-library screening, and therefore may be applicable to identifying human autoantibodies in a variety of disorders including cancers even when antibody elevation is not detected because of a very small number of memory B cells.
    Immunology letters 05/2014; 159(1-2). DOI:10.1016/j.imlet.2014.02.004 · 2.37 Impact Factor
  • Source
    • "The isolation of Ig heavy and light chains by RT-PCR from single sorted B cells allows the generation of recombinant MAbs and thereby detailed studies of antibody repertoires at both the genetic and functional level. Recent studies suggest that this approach is far more efficient than the generation of MAbs through, for example, hybridoma production (Meijer et al., 2006; Tiller et al., 2008; Wrammert et al., 2008; Liao et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Studies in nonhuman primates offer information of high relevance to clinical medicine due to their close genetic relationship with humans. Here, we established an optimized protocol for the isolation of antibody V(D)J sequences from rhesus macaque B cells. Nested PCR primers were designed to align to sequences flanking the V(D)J coding region to enable amplification of highly mutated antibody sequences. The primers were evaluated using cDNA from bulk PBMCs as well as from single-sorted memory and naïve B cells from several macaques to ascertain effective germline coverage. The nested PCR efficiency reached 60.6% positive wells for heavy chain amplification, 39.2% for kappa chain, and 23.7% for lambda chain sequences. Matching heavy and light chain sequences, indicating antibodies that potentially can be cloned, were obtained in 50% of the positive wells. Using these primers, we found that the efficiency and specificity of V(D)J amplifications were markedly improved compared to when primers designed for human Ab isolation were used. In particular, the amplification of recombined light chain VJ sequences was improved. Thus, we describe the design and testing of a new set of rhesus-specific primers that enable efficient and specific amplification of heavy, kappa and lambda V(D)J genes from single sorted B cells. The use of these primers will facilitate future efforts to clone and express rhesus macaque MAbs for genetic, functional and structural analyses.
    Journal of immunological methods 09/2012; 386(1-2):85-93. DOI:10.1016/j.jim.2012.09.003 · 2.01 Impact Factor
Show more